Submitted by Anonymous (not verified) on 11 September 2025 - 15:18
Human medicines European public assessment report (EPAR): Loqtorzi, toripalimab, Date of authorisation: 19/09/2024, Revision: 2, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Loqtorzi, toripalimab, Date of authorisation: 19/09/2024, Revision: 2, Status: Authorised